letter and is arranging for return of all recalled products.
Pharmacies that have Metformin HCl Extended-Release Tablets, USP 750 mg, which is being recalled, should return to the place of purchase.
Consumers should consult a health care professional to obtain a replacement or a different treatment option,” the announcement reads.
“It could be dangerous for patients with type 2 diabetes to stop taking their Metformin without first talking to their health care professional.
Consumers should contact their physician or health care provider if they have experienced any problems that may be related to taking this drug product.”
The FDA is still investigating where NDMA comes from and how it ends up in metformin products.
Most levels found in medications are generally low and fall within the FDA’s accepted daily intake, but recently recalled medications exceed that.
Marksans Pharma Limited, India, however, did not reveal how much NDMA its recalled products contained.
Consumers with medical questions regarding the recall can email Nostrum at [email protected] or call the company at 816-308-4941 Monday through Friday, 9 a.m. to 6 p.m., Eastern time.